SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-19-000011
Filing Date
2019-01-03
Accepted
2019-01-02 21:50:34
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K angiosoma20180930_10k.htm 10-K 904082
2 EXHIBIT 21 ex_131832.htm EX-21 1670
3 EXHIBIT 31.1 ex_132305.htm EX-31.1 9423
4 EXHIBIT 32.1 ex_132306.htm EX-32.1 6092
11 angiosoma_logo.jpg GRAPHIC 8426
  Complete submission text file 0001185185-19-000011.txt   3157886

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT soan-20180930.xml EX-101.INS 394156
6 XBRL TAXONOMY EXTENSION SCHEMA soan-20180930.xsd EX-101.SCH 30630
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20180930_cal.xml EX-101.CAL 28000
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20180930_def.xml EX-101.DEF 182423
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20180930_lab.xml EX-101.LAB 223134
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20180930_pre.xml EX-101.PRE 185935
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55072 | Film No.: 19503534
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1